119 related articles for article (PubMed ID: 2190394)
1. Pharmacokinetic and pharmacodynamic studies of cyclosporine in bone marrow transplantation.
Yee GC
Transplant Proc; 1990 Jun; 22(3):1327-30. PubMed ID: 2190394
[No Abstract] [Full Text] [Related]
2. Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: an analysis of four different assays.
Atkinson K; Downs K; Ashby M; Biggs J
Transplant Proc; 1990 Jun; 22(3):1331-4. PubMed ID: 2190395
[No Abstract] [Full Text] [Related]
3. Cyclosporine-A as prevention for graft-versus-host disease in pediatric patients undergoing bone marrow transplants.
Truog AW; Wozniak SP
Oncol Nurs Forum; 1990; 17(1):39-44. PubMed ID: 2405360
[TBL] [Abstract][Full Text] [Related]
4. The correlation of cyclosporine serum and whole blood concentrations with toxicity and efficacy after human marrow transplantation.
Britton K; Atkinson K; Downs K; Biggs J
Transplant Proc; 1985 Apr; 17(2):1667-70. PubMed ID: 3885501
[No Abstract] [Full Text] [Related]
5. Use of cyclosporine for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
Gluckman E; Devergie A; Lokiec F
Transplant Proc; 1988 Jun; 20(3 Suppl 3):461-9. PubMed ID: 3291282
[No Abstract] [Full Text] [Related]
6. Cyclosporine and graft-versus-host disease after bone marrow transplantation.
N Engl J Med; 1988 Dec; 319(24):1607-8. PubMed ID: 3059188
[No Abstract] [Full Text] [Related]
7. Comparison of two intravenous cyclosporine infusion schedules in marrow transplant recipients.
Tallman MS; Nemunaitis JJ; McGuire TR; Yee GC; Hughes TE; Almgren JD; Appelbaum FR; Higano CS; McGuffin RW; Singer JW
Transplantation; 1988 Apr; 45(4):810-3. PubMed ID: 3282363
[No Abstract] [Full Text] [Related]
8. Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias.
Mrsić M; Labar B; Bogdanić V; Nemet D; Pavletić Z; Plavsić F; Dobrić I; Kastelan A; Marusić M; Zupancić-Salek S
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():95-6. PubMed ID: 2697416
[No Abstract] [Full Text] [Related]
9. Decreased incidence and severity of graft-versus-host disease in HLA matched and mismatched marrow recipients of cyclosporine and methotrexate.
Tollemar J; Ringdén O; Heimdahl A; Lönnqvist B; Sundberg B
Transplant Proc; 1988 Jun; 20(3 Suppl 3):470-9. PubMed ID: 3291283
[No Abstract] [Full Text] [Related]
10. Cyclosporine in children.
Polchi P; Lucarelli G; Galimberti M; Moretti L
Prog Clin Biol Res; 1989; 309():333-48. PubMed ID: 2675102
[No Abstract] [Full Text] [Related]
11. [Cyclosporin A].
Gabrielli A; Rupoli S
Recenti Prog Med; 1985 Jun; 76(6):326-31. PubMed ID: 3903888
[No Abstract] [Full Text] [Related]
12. Cyclosporine-induced graft vs host disease in two patients receiving syngeneic bone marrow transplants.
Dale BM; Atkinson K; Kotasek D; Biggs JC; Sage RE
Transplant Proc; 1989 Oct; 21(5):3816-7. PubMed ID: 2815290
[No Abstract] [Full Text] [Related]
13. Combination low-dose thalidomide and cyclosporine prophylaxis for acute graft-versus-host disease in a rat mismatched model.
Vogelsang GB; Wells MC; Santos GW; Chen TL; Hess AD
Transplant Proc; 1988 Apr; 20(2 Suppl 2):226-8. PubMed ID: 3284069
[No Abstract] [Full Text] [Related]
14. Bone marrow transplantation with ciclosporin.
Gratwohl A; Speck B
Prog Allergy; 1986; 38():404-31. PubMed ID: 3523495
[No Abstract] [Full Text] [Related]
15. Performance of the Sandoz radioimmunoassays for cyclosporine.
Holt DW; Marsden JT; Fashola TO; Johnston A
Transplant Proc; 1990 Jun; 22(3):1155-9. PubMed ID: 2349678
[No Abstract] [Full Text] [Related]
16. Japanese conference on cyclosporine blood level monitoring.
Takagi H; Uchida K
Transplant Proc; 1990 Jun; 22(3):1224-5. PubMed ID: 2190384
[No Abstract] [Full Text] [Related]
17. Cyclosporin A (CsA): pharmacokinetics, clinical monitoring and pharmacodynamics in bone marrow transplantation (BMT).
Carreras Pons E
Prog Clin Biol Res; 1989; 309():325-32. PubMed ID: 2675101
[No Abstract] [Full Text] [Related]
18. Syngeneic graft-versus-host disease after allogeneic bone marrow transplantation and cyclosporine treatment.
Hess AD; Vogelsang GB; Silanskis M; Friedman KA; Beschorner WE; Santos GW
Transplant Proc; 1988 Jun; 20(3 Suppl 3):487-92. PubMed ID: 3291285
[No Abstract] [Full Text] [Related]
19. [Cyclosporine as prophylaxis for graft versus host disease in adults undergoing allogeneic bone marrow transplantation].
Matsushita T; Akatsuka Y; Towatari M; Takeyama K; Miyamura K; Sugihara T; Minami S; Kodera Y
Rinsho Ketsueki; 1989 Apr; 30(4):429-36. PubMed ID: 2671437
[TBL] [Abstract][Full Text] [Related]
20. Low incidence of severe acute and chronic graft-versus-host disease as a result of prolonged cyclosporine prophylaxis and early aggressive treatment with corticosteroids.
Ruutu T; Volin L; Elonen E
Transplant Proc; 1988 Jun; 20(3):491-3. PubMed ID: 3289191
[No Abstract] [Full Text] [Related]
[Next] [New Search]
